C. albicans, or candida, is known to cause yeast infections. In some cases, it develops into invasive candidiasis, a potentially fatal infection occurring mostly in patients with compromised immunity.

Caspofungin was approved for use in Costa Rica in October 2001 (Cancidas; Merck Sharp and Dohme) for patients older than 16 years, with invasive Candida spp. or Aspergillus spp. that fail to ...

The present article reviews these aspects for invasive aspergillosis and invasive candidiasis, the two most common life-threatening fungal infections. Among immunosuppressed children, the impact ...

If people leave oral thrush untreated, the candidiasis may travel to their esophagus or turn into something more serious ...

An increased risk of both invasive and superficial fungal infections was observed among patients who received TNF-α inhibitors for various conditions.

Cases of Candida auris, a dangerous, drug-resistant fungus, are rising in hospitals and senior care centers across the U.S.

The World Health Organization (WHO) this week published two reports spotlighting gaps in adequate medicines and diagnostic ...

Candidiasis is the term for an infection from Candida yeast. Invasive candidiasis is an infection inside your body. It can impact internal organs or other parts of your body. Acute hematogenous ...

Fungal infections in India are rising, with growing resistance to treatment. Learn about common types, causes, drug ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today ...